Cell Origins of High-Grade Serous Ovarian Cancer

Cell Origins of High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most common and deadliest type of ovarian cancer. HGSC appears to arise from the ovary, fallopian tube, or peritoneum. As most HGSC cases present with widespread peritoneal metastases, it is often not clear wh...

Full description

Bibliographic Details
Main Authors:	Jaeyeon Kim, Eun Young Park, Olga Kim, Jeanne M. Schilder, Donna M. Coffey, Chi-Heum Cho, Robert C. Bast
Format:	Article
Language:	English
Published:	MDPI AG 2018-11-01
Series:	Cancers
Subjects:	ovarian cancer epithelial ovarian cancer high-grade serous ovarian cancer (HGSOC) high-grade serous carcinoma (HGSC) ovarian cancer origin fallopian tube ovarian surface epithelium (OSE) serous tubal intraepithelial carcinoma (STIC)
Online Access:	https://www.mdpi.com/2072-6694/10/11/433

Similar Items

Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer
by: Jung Mi Byun, et al.
Published: (2023-01-01)

Immunoexpression of p53 and p16 in Low and High-grade Serous Ovarian Cancer: A Cross-sectional Study
by: Ranajit Mandal, et al.
Published: (2023-11-01)

Association of Epithelial Changes in Fallopian Tube and Epithelial Neoplasms of Ovary using p53 Tumour Marker- A Cross-sectional Study in a Tertiary Care Centre
by: VANDANA MAROO, et al.
Published: (2021-12-01)

Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
by: Mitchell Acland, et al.
Published: (2020-12-01)

The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction
by: Racheal Louise Johnson, et al.
Published: (2021-12-01)

Incidence of pelvic high-grade serous carcinoma after isolated STIC diagnosis: A systematic review of the literature
by: Valerie Catherine Linz, et al.
Published: (2022-08-01)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
by: Maho Shimizu, et al.
Published: (2021-06-01)

Digital pathology-based study of cell- and tissue-level morphologic features in serous borderline ovarian tumor and high-grade serous ovarian cancer
by: Jun Jiang, et al.
Published: (2021-01-01)

CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary
by: Shoumei Bai, et al.
Published: (2019-11-01)

Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro
by: Yilin Dai, et al.
Published: (2024-01-01)

Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment
by: Marcus Vetter, et al.
Published: (2022-11-01)

Clinical outcomes following identification of an incidental p53 signature in the fallopian tube
by: Emily C. MacARTHUR, et al.
Published: (2024-04-01)

Lipid Droplet Accumulation Independently Predicts Poor Clinical Prognosis in High-Grade Serous Ovarian Carcinoma
by: Naoyuki Iwahashi, et al.
Published: (2021-10-01)

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
by: Michalis Liontos, et al.
Published: (2021-03-01)

Salpingectomy and prevention of ovarian carcinoma
by: Shahul Hameed Mohamed Siraj, et al.
Published: (2016-08-01)

A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors
by: Kristýna Němejcová, et al.
Published: (2023-02-01)

UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
by: Laura R. Hardy, et al.
Published: (2018-08-01)

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
by: Takuma Ohsuga, et al.
Published: (2017-08-01)

Synchronous bilateral primary ovarian cancer with right endometroid carcinoma and left high-grade serous carcinoma: a case report and literature review
by: Mimori Fujimori, et al.
Published: (2022-04-01)

The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination
by: Sabrina J. Ritch, et al.
Published: (2022-04-01)

Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer
by: Rachel Kerslake, et al.
Published: (2022-10-01)

A Protocol for the Acquisition of Comprehensive Proteomics Data from Single Cases Using Formalin-Fixed Paraffin Embedded Sections
by: Mitchell Acland, et al.
Published: (2022-07-01)

Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
by: Lu Zhang, et al.
Published: (2021-11-01)

Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations
by: Isao Otsuka
Published: (2021-04-01)

The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers
by: Chiara M. Biatta, et al.
Published: (2023-08-01)

Prognostic Value of Chemotherapy Response Score (CRS) Assessed on the Adnexa in Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis
by: Angela Santoro, et al.
Published: (2022-03-01)

Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models
by: Rachel Kerslake, et al.
Published: (2023-06-01)

T-Cell Receptor Repertoire Characteristics Associated with Prognostic Significance in High-Grade Serous Ovarian Carcinoma
by: Ju-Won Kim, et al.
Published: (2023-03-01)

Molecular Management of High-Grade Serous Ovarian Carcinoma
by: Paula Punzón-Jiménez, et al.
Published: (2022-11-01)

Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond <i>BRCA1</i> and <i>BRCA2</i>
by: David Samuel, et al.
Published: (2022-02-01)

Characterization of Primary Mucinous Ovarian Cancer by Diffusion-Weighted and Dynamic Contrast Enhancement MRI in Comparison with Serous Ovarian Cancer
by: Laretta Grabowska-Derlatka, et al.
Published: (2023-02-01)

High-grade serous ovarian carcinoma organoids as models of chromosomal instability
by: Maria Vias, et al.
Published: (2023-05-01)

CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
by: Katrin Kleinmanns, et al.
Published: (2020-06-01)

Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
by: Chiara Romani, et al.
Published: (2020-08-01)

The Role of the Extracellular Matrix and Tumor-Infiltrating Immune Cells in the Prognostication of High-Grade Serous Ovarian Cancer
by: Yuri Belotti, et al.
Published: (2022-01-01)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
by: Puja Dey, et al.
Published: (2022-03-01)

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer
by: Nicholas Cardillo, et al.
Published: (2022-07-01)

Screening and Prevention for High-Grade Serous Carcinoma of the Ovary Based on Carcinogenesis—Fallopian Tube- and Ovarian-Derived Tumors and Incessant Retrograde Bleeding
by: Isao Otsuka, et al.
Published: (2020-02-01)

Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein
by: Mariana Nunes, et al.
Published: (2021-10-01)

Proteome profiling of low grade serous ovarian cancer
by: Haniyeh Bashi zadeh fakhar, et al.
Published: (2019-07-01)